Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
Pause your taper for 2 to 4 weeks at your current dose level, reinforce behavioral strategies, and reassess with your provider before resuming reduction
It is the most abundant intracellular antioxidant in the human body and plays a fundamental role in cellular defense, detoxification, and metabolic regulation
Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing
And in 2022, I started Mounjaro (tirzepatide), which is FDA-approved for type 2 diabetes but used off-label for weight loss
Caspase-4/5/11 can also activate the NLRP3 inflammasome, which subsequently activates caspase-1, resulting in the production and release of IL-1 and IL-18 (Sahoo et al., 2023)